PortfoliosLab logoPortfoliosLab logo
Concord Medical Services Holdings Limited (CCM)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US2062771058
CUSIP
206277105
IPO Date
Dec 11, 2009

Highlights

Market Cap
$559.16K
Enterprise Value
$5.02B
EPS (TTM)
-$1.12K
Total Revenue (TTM)
$365.76M
Gross Profit (TTM)
-$41.85M
EBITDA (TTM)
-$358.51M
Year Range
$3.18 - $10.77
ROA (TTM)
-2.42%
ROE (TTM)
7.28%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Concord Medical Services Holdings Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Concord Medical Services Holdings Limited (CCM) has returned -0.52% so far this year and -4.00% over the past 12 months. Over the last ten years, CCM has returned -22.62% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Concord Medical Services Holdings Limited

1D
0.00%
1M
5.49%
YTD
-0.52%
6M
-37.46%
1Y
-4.00%
3Y*
-32.47%
5Y*
-36.77%
10Y*
-22.62%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Dec 11, 2009, CCM's average daily return is +0.09%, while the average monthly return is -0.05%.

Historically, 45% of months were positive and 55% were negative. The best month was Apr 2025 with a return of +112.8%, while the worst month was May 2024 at -41.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, CCM closed higher 42% of trading days. The best single day was Dec 15, 2020 with a return of +179.5%, while the worst single day was Jun 5, 2024 at -46.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.18%-10.34%5.49%-0.52%
2025-3.34%-0.19%-22.93%112.75%-14.22%-21.51%-13.09%4.91%17.52%-11.07%-29.12%-0.26%-28.25%
2024-29.45%-36.90%12.93%53.71%-41.16%89.96%-17.11%-17.59%8.01%10.24%-34.13%5.70%-51.09%
2023-18.29%5.97%-12.17%6.64%2.26%1.47%2.84%-2.76%-7.25%-12.50%-9.82%8.91%-32.93%
2022-3.00%8.76%-18.96%-12.87%8.72%16.05%4.79%-1.02%-5.13%-30.81%17.97%8.61%-18.00%
202131.02%0.28%6.67%-11.46%-2.94%-13.03%3.83%-15.10%22.13%-20.23%-8.32%-11.50%-27.01%

Benchmark Metrics

Concord Medical Services Holdings Limited has an annualized alpha of 20.77%, beta of 0.35, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since December 14, 2009.

  • This stock tended to rise when S&P 500 Index fell (downside capture of -16.00%), but participation in market rallies was also limited (-51.30%) — a profile typical of counter-cyclical assets.
  • Beta of 0.35 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
20.77%
Beta
0.35
0.00
Upside Capture
-51.30%
Downside Capture
-16.00%

Return for Risk

Risk / Return Rank

CCM ranks 40 for risk / return — below 40% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


CCM Risk / Return Rank: 4040
Overall Rank
CCM Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
CCM Sortino Ratio Rank: 4545
Sortino Ratio Rank
CCM Omega Ratio Rank: 4444
Omega Ratio Rank
CCM Calmar Ratio Rank: 3535
Calmar Ratio Rank
CCM Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Concord Medical Services Holdings Limited (CCM) and compare them to a chosen benchmark (S&P 500 Index).


CCMBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.04

0.90

-0.94

Sortino ratio

Return per unit of downside risk

0.66

1.39

-0.73

Omega ratio

Gain probability vs. loss probability

1.08

1.21

-0.13

Calmar ratio

Return relative to maximum drawdown

-0.20

1.40

-1.60

Martin ratio

Return relative to average drawdown

-0.30

6.61

-6.90

Explore CCM risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Concord Medical Services Holdings Limited provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%5.00%10.00%15.00%20.00%$0.00$2.00$4.00$6.00$8.00$10.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$9.80

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%20.25%

Monthly Dividends

The table displays the monthly dividend distributions for Concord Medical Services Holdings Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Concord Medical Services Holdings Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Concord Medical Services Holdings Limited was 95.30%, occurring on Feb 23, 2026. The portfolio has not yet recovered.

The current Concord Medical Services Holdings Limited drawdown is 94.74%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.3%Mar 6, 20143010Feb 23, 2026
-72.53%Jan 21, 2010607Jun 15, 2012422Feb 21, 20141029
-10.42%Dec 14, 20097Dec 22, 200910Jan 7, 201017
-3.98%Feb 25, 20141Feb 25, 20141Feb 26, 20142
-3.43%Jan 11, 20103Jan 13, 20103Jan 19, 20106

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Concord Medical Services Holdings Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Concord Medical Services Holdings Limited is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CCM relative to other companies in the Medical Care Facilities industry. Currently, CCM has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items